Open AccessNonobstructive azoospermia, when we can find spermatozoa, is FSH as a marker of succes?
Author(s) -
A. Khelaia
Publication year - 2021
Publication title -
urologìâ
Language(s) - English
Resource type - Journals
eISSN - 2709-5576
pISSN - 2307-5279
DOI - 10.26641/2307-5279.25.2.2021.238226
Subject(s) - azoospermia , andrology , obstructive azoospermia , semen , gynecology , oligospermia , medicine , population , male infertility , urology , infertility , biology , pregnancy , genetics , environmental health
Azoospermia is the absence of spermatozoa in ejaculate even after semen centrifugation at least two times. Azoospermia due to spermatogenic failure – non-obstructive azoospermia (NOA) observed in 1% of population and in 10–15% of infertile men. Predictive factors for the presence of spermatozoa in testis are still under debate. The development of ICSI revolutionized management of azoospermia. In our practice we advised TESA as a first step and FSH can predict the success. According serum FSH levels we divided our men in three groups: FSH 15 mU/ml. We tried to evaluated SRR in accordance serum FSH level and find significant difference. In 117 men with FSH 15 mU/ml (45 cases from 131). At the same time, we make embryologist personal assessment (EPA) and try to show embryologist crucial role in tissue assessment after TESA. Another crucial point of discussion – histomorphology within the testis in NOA and indications for re – TESA after 3–6 months.